HIV Weekly Pill Advances, HPV Vaccine Saves Lives, AI Data Center Controversy, and More

At the 26th International AIDS Conference in Rio de Janeiro, new findings showed that a weekly pill combining drugs from Gilead and Merck could effectively control HIV, which is a big step forward from the usual daily pills. However, there are still hurdles in creating a vaccine, and U.S. funding cuts have reduced HIV/AIDS aid from $8.3 billion in 2024 to $6.2 billion for 2025, leading to the shutdown of 1,700 HIV service locations across 46 countries. Meanwhile, in England, the HPV vaccine has nearly eliminated cervical cancer deaths in women under 30, with no reported deaths among those in their early 20s from 2020 to 2024. The late Dr. Maura Gillison, who linked HPV to oropharyngeal cancers, was commemorated. In Effingham County, Georgia, local worries have arisen over OpenAI's $20 billion plan to build a data center, especially regarding transparency and environmental impacts. Additionally, studies from Georgia's salt marshes show that rising sea levels are harming the Spartina alterniflora roots, threatening the ecosystem. Lastly, Wendell Berry's essay on technology's influence in society was highlighted.